Jerry Yang

Jerry Yang is an experienced venture capital professional currently serving as a Venture Partner at Global Brain, a leading Japanese venture capital firm based in Tokyo. His career in venture capital spans over a decade, with a significant focus on early to growth-stage technology companies across Asia. Prior to joining Global Brain in July 2019, Yang held key investment roles at GREE Ventures (now known as STRIVE), where he served as a Venture Partner and Investment Director. His extensive background in institutional venture capital positions him as a key decision-maker in the firm's investment processes.

At Global Brain, Yang contributes to the firm's broad investment strategy, which targets companies from the seed stage through to pre-IPO rounds. Global Brain is known for its robust fund sizes, including its Global Brain 8 (GB-8) fund, which closed at JPY 25 billion (approximately $160 million USD). The firm's typical investment range for initial checks, as stated on their official website, spans from "several tens of millions of yen to several hundreds of millions of yen" per company. This translates to an approximate range of $130,000 USD on the lower end, suitable for seed or very early-stage investments, up to $5.8 million USD for more mature early-stage or Series A/B rounds.

Yang's investment focus aligns with Global Brain's strategic geographical priorities, which include Japan, Southeast Asia, and India. He is actively involved in identifying promising startups, conducting due diligence, and supporting portfolio companies. His role as an Advisory Board Member for Sarcura further highlights his engagement with innovative technology companies, particularly in the deep tech or healthcare sectors, reflecting a broader interest in impactful technological advancements.

Given his position within a well-established VC firm and the firm's stated investment parameters, Jerry Yang primarily invests institutional capital rather than personal angel investments. His investment decisions are guided by Global Brain's fund mandates and investment theses, aiming to generate significant returns for their limited partners by backing high-potential startups in key Asian markets.